2 August 2024 - To date, no vaccine against dengue fever was authorised in Switzerland. ...
24 July 2024 - According to a recent study, medicines are approved on average 249 days later in Switzerland than by ...
1 July 2024 - In order to standardise practice, Swissmedic will in future publish both the proposed and approved indications in ...
29 May 2024 - Scientific analysis confirms successful Swissmedic participation in international initiative to expedite access to innovative cancer drugs. ...
13 May 2024 - Expedited market access for novel and efficacious drugs is warranted for patients. Since 2020, Swissmedic (The Swiss ...
22 February 2024 - Curium announced today that the marketing authorisation application for Pylclari (piflufolastat (18F)) submitted by exclusive Swiss ...
28 December 2023 - Following a thorough review, Swissmedic has authorised the medicinal product Beyfortus from marketing authorisation holder Sanofi-Aventis (Suisse). ...
18 December 2023 - The manufacturer Novavax is no longer pursuing marketing authorisation for its COVID-19 vaccine in Switzerland. ...
11 December 2023 - Orchard Therapeutics today announced the Swiss Agency for Therapeutic Products (Swissmedic) has approved Libmeldy (atidarsagene autotemcel), a ...
30 October 2023 - New rules for the reimbursement of orphan drugs and other unlisted medicines will become effective in Switzerland ...
28 September 2023 - Spikevax XBB.1.5 approved for persons aged 18 and over ...
21 September 2023 - From a regulator's point of view, a market authorisation can only be granted with a positive benefit-risk ...
21 August 2023 - While lagging other regulators in bringing new drugs to market, Swiss regulators say their review times ...
13 July 2023 - Swissmedic examining application for vaccine against Omicron subvariant XBB.1.5 ...
5 July 2023 - Moderna has submitted marketing authorization applications for the investigational RSV vaccine, mRNA-1345, with the European Medicines Agency, ...